Print

Bristol-Myers Squibb Company (BMY) (JOBS) Still Hungry for Deals After Medarex, Inc. (MEDX) (JOBS)  
9/24/2009 7:19:46 AM

Bookmark and Share

Reuters -- Bristol-Myers Squibb Co's $2.4 billion acquisition of biotechnology company Medarex has not quenched its thirst for takeovers as it faces the 2011 patent expiration on Plavix, its biggest-selling drug, the company's head of research and development said.